BioVaria 2019, 8 – 9 mei, München: Sterk aanbod van technologieën, sprekers en start-ups
MUNICH-(BUSINESS WIRE)- Ascenion is trots om een sterke line-up van sprekers, deelnemers, technologieën en start-ups te presenteren. Besluitvormers uit de biotechnologie, farmacie en financiën komen samen in München om zich te verdiepen in commercieel aantrekkelijke academische uitvindingen en partnerschappen aan te gaan met onderzoeksteams, ondernemers en professionals op het gebied van technologieoverdracht uit heel Europa.
Bent u:
-
- een scout of business developer uit de internationale biofarmaceutische industrie die op zoek is naar geavanceerde uitvindingen om de R&D-portefeuilles van uw bedrijf aan te vullen,
-
- een investeerder in biowetenschappen die op zoek is naar aantrekkelijke start-ups of IP-activa als investeringsmogelijkheden,
-
- een professional of wetenschapper op het gebied van technologieoverdracht van openbare onderzoeksinstellingen die over door een octrooi beschermde technologieën beschikt voor het verlenen van licenties of partnerschappen,
mis dan niet de mogelijkheid om u te registeren voor BioVaria 2019 van 8 – 9 mei!
BioVaria 2019, 8 – 9 May, Munich: Strong Line-up of Technologies, Speakers and Startups
MUNICH–(BUSINESS WIRE)– Ascenion is proud to present a strong line-up of speakers, participants, technologies and startups. Decision makers from biotech, pharma and finance will come together in Munich to learn about commercially attractive academic inventions and initiate partnerships with research teams, entrepreneurs and technology transfer professionals from all over Europe.
Whether you are
-
- a scout or business developer from the international biopharmaceutical industry looking for cutting-edge inventions to complement your companies’ R&D portfolios,
-
- a life-science investor looking for attractive startups or IP assets as investment opportunities,
-
- a technology transfer professional or scientist from public research institutions who has patent-protected technologies available for licensing or partnering,
then do not miss to register for BioVaria 2019 to be held on 8 – 9 May!
66 peer-selected, patent-protected technologies originating from as many research institutes, universities and university hospitals will be featured.
Further program highlights include a panel discussion on “From stem cells to therapy: Development of cell based approaches in regenerative medicine” and BioVaria’s dedicated Startup Pitch & Partner program which provides attractive opportunities for entrepreneurs and venture capitalists.
Preview BioVaria’s Technologies and Startups online
-
- Explore the technologies presented in 10-min oral presentations and posters!
-
- Get a first impression of the participating startups!
Register now at www.biovaria.org
Patron:
Bavarian Ministry of Economic Affairs, Regional Development and Energy
Sponsors:
BioM, Abbvie, Else Kröner-Fresenius-Stiftung, ISAR Bioscience, Johnson & Johnson Innovation, HERTIN & Partner, Kador & Partner, NLC, Vossius & Partner
Startup Sponsors:
24IP Law Group, Accelero Bioanalytics, Charles River, German Accelerator Life Sciences, IASON Consulting, K&L Gates, LSI Life Science Inkubator, LSP, ttopstart, TVM Capital Life Science
Technology transfer partners:
Ascenion, Austria Wirtschaftsservice Gesellschaft, BayPAT, DKFZ – German Cancer Research Center, DZIF – German Center for Infection Research, EMBLEM Technology Transfer, IOCB Tech, Lead Discovery Center, LMU Munich, Max Planck Innovation, Netval, PROvendis, TechnologieAllianz, University of Pardubice, VIS
Network partners:
ASTP-Proton, BIO Deutschland, BioRN
Media partners:
Business Wire, Going Public, LABIOTECH.eu, transkript
View source version on businesswire.com: https://www.businesswire.com/news/home/20190429005250/en/
Contacts
Ascenion GmbH
Esther Lange
T: +49 (0)89 318814-22
lange@ascenion.de